Key result
MIF-2 blockade curbs atherosclerosis and vascular inflammation, while human levels correlate with CAD severity.
Answers are grounded in this paper and cite their sources.
MIF-2 acts as an atypical chemokine linking vascular inflammation to metabolic dysfunction, and its blockade protects against atherosclerosis and hepatic lipogenesis in preclinical models.
Atherosclerosis is the underlying cause of myocardial infarction and ischemic stroke. It is a lipid-triggered and cytokine/chemokine-driven arterial inflammatory condition. We identify D-dopachrome tautomerase/macrophage migration-inhibitory factor-2 (MIF-2), a paralog of the cytokine MIF, as an atypical chemokine promoting both atherosclerosis and hepatic lipid accumulation. In hyperlipidemic Apoe –/– mice, Mif-2 -deficiency and pharmacological MIF-2-blockade protect against lesion formation and vascular inflammation in early and advanced atherogenesis. MIF-2 promotes leukocyte migration, endothelial arrest, and foam-cell formation, and we identify CXCR4 as a receptor for MIF-2. Mif-2- deficiency in Apoe –/– mice leads to decreased plasma lipid levels and suppressed hepatic lipid accumulation, characterized by reductions in lipogenesis-related pathways, tri-/diacylglycerides, and cholesterol-esters, as revealed by hepatic transcriptomics/lipidomics. Hepatocyte cultures and FLIM-FRET-microscopy suggest that MIF-2 activates SREBP-driven lipogenic genes, mechanistically involving MIF-2-inducible CD74/CXCR4 complexes and PI3K/AKT but not AMPK signaling. MIF-2 is upregulated in unstable carotid plaques from atherosclerotic patients and its plasma concentration correlates with disease severity in patients with coronary artery disease. These findings establish MIF-2 as an atypical chemokine linking vascular inflammation to metabolic dysfunction in atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Bounkari et al. (2025) studied Atherosclerosis and coronary artery disease. MIF-2 deficiency and pharmacological MIF-2-blockade was evaluated on Lesion formation, vascular inflammation, and hepatic lipid accumulation.
Synapse has enriched 10 related papers. Consider them for comparative context: